长期预后的预测因素集中在慢性冠状动脉综合征患者的功能上
Katarzyna Charkiewicz-Szeremeta1,2, Emilia Sawicka-Śmiarowska3, Marlena Dubatówka1
1Department of Population Medicine and Lifestyle Diseases Prevention, Medical University of Bialystok, 15-269 Bialystok, Poland.
Diseases (Basel, Switzerland)
|February 26, 2026
概括
根据eGFR和白蛋白尿的指标,功能显著影响慢性冠状动脉综合征 (CCS) 患者的存活率. 监测hsCRP,血红蛋白和LVEF有助于识别高风险个体,以获得更好的长期结果.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 公共卫生 公共卫生
背景情况:
- 慢性冠状动脉综合征 (CCS) 的患病率越来越高,原因是预期寿命和风险因素的增加.
- 心血管疾病仍然是全球主要的死亡和发病原因.
- 专注于功能参数,如估计的淋巴膜过率 (eGFR) 和白皮素尿 (uACR),以评估长期存活率.
研究的目的:
- 确定与CCS患者的长期存活相关的因素.
- 具体研究功能 (eGFR和白蛋白尿) 在CCS患者预后中的作用.
- 确定CCS中死亡风险分层的关键临床标志物.
主要方法:
- 该研究包括257名因急性冠状动脉综合征或再血管化而住院的患者 (年龄≤80岁).
- 进行了长达80个月的随访期.
- 通过eGFR和白蛋白尿 (uACR) 评估功能;用于功能障碍分类的KDIGO标准.
主要成果:
- 降低EGFR和增加白蛋白尿 (ACR) 与增加的死亡率有关.
- 与死亡率密切相关的因素包括血红蛋白降低,左下心室喷射率 (LVEF) 和高hsCRP.
- 在幸存者中观察到平常范围内更高的透静血压.
结论:
- 与EGFR一起测量白色素尿,改善了CCS患者的心血管风险分类.
- hsCRP,血红蛋白度和LVEF对于识别高死亡风险的CCS患者至关重要.
- 优化风险分层化为CCS患者提供了适当的治疗策略.
相关概念视频
01:28Chronic Kidney Disease III: Interprofessional Care
508
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
508
01:25Chronic Kidney Disease I: Introduction
843
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
843
01:29Acute Kidney Injury III: Clinical Manifestations
1.1K
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.1K
01:18Chronic Kidney Disease IV: Nursing Management
455
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
455
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
376
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
376
01:24Chronic Kidney Disease II: Clinical Manifestations
768
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
768